Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incobotulinumtoxin Versus Onabotulinumtoxin in the Treatment of Patients With Overactive Bladder Syndrome

NCT03758235 is registered in ClinicalTrials.gov with University Of Perugia as lead sponsor.

NCT NCT03758235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03758235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incobotulinumtoxin Versus Onabotulinumtoxin in the Treatment of Patients With Overactive Bladder Syndrome
Lead sponsor
University Of Perugia
Phase
Phase 3
Overall status
Unknown status
Start date
September 1, 2018
Completion date
September 1, 2021
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder syndrome